Hi FP, great post. The further IMU progress along with their pipeline the valuation SHOULD reflect this, on positive news for each of the vaccines in various stages of development & clinical trials, but it isn’t & yes remembering thinking wow, 4c isn’t so much in Immuno-Oncology in regards to Edison report.
I guess Mr Market may be looking at our huge share registry & dilution as a ‘put off’ to investment. But is it such a huge issue in the Immuno-Oncology space when we have seen multiple early stage M&A with big Pharma recently in the billions of dollars?
In no way am I saying this is a definate for IMU, I think it will take Ph2 trials to be more convincing of their vaccines & value of IP to the market, but it certainly is something to consider & the C word (consolidation) may not be necessary for this company.
In the mean time, thanks Mr Market for the opportunity to accumulate well below valuation & maybe sometime in the near future, IMU won’t be flying so far under the radar. Just my thoughts on this, DYOR. Have a great weekend all.
- Forums
- ASX - By Stock
- IMU
- Ann: Investor Presentation
Ann: Investor Presentation, page-45
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M |
Open | High | Low | Value | Volume |
7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 605784 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 159880 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 605784 | 0.067 |
19 | 2180735 | 0.066 |
20 | 2260954 | 0.065 |
9 | 3671083 | 0.064 |
6 | 674800 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 159880 | 2 |
0.069 | 1070351 | 8 |
0.070 | 1000281 | 7 |
0.071 | 2660302 | 12 |
0.072 | 1439858 | 6 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |